Companies

Elanco Animal Health Inc

NYSE: ELAN
$26.43
▼ $0.35 (−1.31%) today
Markets closed · 5:35pm ET

24/7 Wall St. View

ELAN at a Glance

Price
24/7 target
$37.28
Street target
$31.00

NYSE: ELAN

About Elanco Animal Health

Elanco Animal Health Incorporated (NYSE: ELAN) is an animal health company with more than 70 years of heritage. It develops, manufactures and markets products and services to prevent and treat disease in pets and farm animals.

The business has two main segments:
- **Pet Health:** Parasiticides and dermatology therapies sold through veterinarians and retail channels. Key products include Zenrelia, a JAK inhibitor for canine dermatitis; Credelio Quattro, a broad-spectrum parasiticide and now its largest U.S. Pet Health brand; Befrena; AdTab; and the Advantage and Seresto families.
- **Farm Animal:** Cattle, poultry and swine products. Global ruminants (beef and dairy) are currently its fastest-growing species.

Elanco also earns contract manufacturing, royalty and milestone revenue. Some royalty and milestone streams have been sold to a third party but are still recognized under GAAP. In April 2026 the company acquired AHV International B.V.

The company is pursuing growth through its innovation portfolio, targeting [USD:1275000000] of innovation revenue in 2026, and international launches such as Credelio Quattro in the EU in Q1 2027. It is pursuing productivity through its Elanco Ascend initiative. It has deleveraged to a net leverage ratio of 2.9x and does not currently plan to pay dividends. Updated

Latest Activity

ELANElanco Animal Health
Q3 2026
EPS
$0.27
est $0.20+32.8%
Revenue
$1.26B
est $1.21B+4.8%

Management passed the entire beat through to guidance, lifting full-year adjusted EPS to $1.17 to $1.20 from $1.10 to $1.16. Pet Health carried it, up 14% as Zenrelia and Credelio Quattro each posted their biggest revenue quarter yet and hit new share highs in September. That is four straight quarters of topping consensus.

Quarterly EPS — reported vs estimate

ELAN Coverage

Frequently Asked Questions

What does Elanco Animal Health do?

Elanco Animal Health Incorporated (NYSE: ELAN) is an animal health company with more than 70 years of heritage. It develops, manufactures and markets products and services to prevent and treat disease in pets and farm animals.

What is the ELAN stock price target?

24/7 Wall St.'s 12-month price target for ELAN is $37.28, rated Buy. The Wall Street consensus target is $31.00. ELAN price prediction →